Clinical value of determination of markers of a thrombophylia at patients with the complicated pregnancy in the anamnesis
- 作者: Andreeva M.D.1
 - 
							隶属关系: 
							
- Kuban state medical university
 
 - 期: 卷 64, 编号 2 (2015)
 - 页面: 13-17
 - 栏目: Articles
 - URL: https://ogarev-online.ru/jowd/article/view/1257
 - DOI: https://doi.org/10.17816/JOWD64213-17
 - ID: 1257
 
如何引用文章
全文:
详细
作者简介
Margarita Andreeva
Kuban state medical university
														Email: andreeva_md@mail.ru
				                					                																			                								Phd, Associate Professor, department of obstetrics, gynecology and perinatology, Faculty of advanced training and professional retraining of specialists				                														
参考
- Самбурова Н. В. Клиническое значение контроля маркеров активации свертывания крови при проведении противотромботической терапии у беременных, рожениц и родильниц с тромбофилией: дис… канд. мед. наук. М. 2008; 132 с.
 - Тромбогеморрагические осложнения в акушерско-гинекологической практике: Руководство для врачей. Под ред. А. Д. Макацария. М. 2011; 1056 с.
 - Kovac M., Mitic G. et al. Thrombophilia in women with pregnancy-associated complications: fetal loss and pregnancy-related venous thromboembolism. Gynecol. Obstet. Invest. 2010; 69 (4): 233-8.
 - Lykke J. A., Bare L. A., Olsen J. et al. Thrombophilias and adverse pregnancy outcomes: results from the Danish National Birth Cohort. J. Thromb. Haemost. 2012; 10 (7): 1320-5.
 - Pabinger I. Thrombophilia and its impact on pregnancy. Thromb Res. 2009; 123 (3): 16-21.
 - Rodger M. A. An update on thrombophilia and placenta mediated pregnancy complications: What should we tell our patients? Thromb. Res. 2013; 131 (1): 25-7.
 
补充文件
				
			
						
						
					
				

